In order to achieve his vision, though, he needed to leave OpenAI. “There’s a lot of misinformation out there” about why he ...
23andMe said Monday it will lay off more than 200 employees, about 40% of its staff, and restructure the company amid its financial challenges. The genetic testing firm will discontinue the ...
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback